18F-FDG-PET is not currently recommended for use in the diagnosis of cranial giant cell arteritis (GCA). A new study has compared 18F-FDG-PET with temporal artery biopsy and clinical diagnosis as gold standards, but is 18F-FDG-PET accurate enough to be used on temporal arteries?
-
2019 (v1)PublicationUploaded on: August 27, 2024
-
2018 (v1)Publication
Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease in the elderly after rheumatoid arthritis. It is clinically characterised by pain and stiffness in the neck, proximal shoulder and hip girdle. Glucocorticoids (GCs) are the cornerstone of PMR treatment, but they are associated with potentially severe side...
Uploaded on: August 27, 2024 -
2021 (v1)Publication
No description
Uploaded on: August 27, 2024 -
2019 (v1)Publication
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are common inflammatory diseases of the elderly. They have variable clinical courses and are usually treated with glucocorticoids (GCs). Relapses are frequent in both conditions. Physicians should balance the tradeoff of treatment-related adverse events and risk of relapse. The...
Uploaded on: August 27, 2024 -
2019 (v1)Publication
Polymyalgia rheumatica is an inflammatory rheumatic disease of the elderly characterised by pain and stiffness in the neck and pelvic girdle, and is the second most common inflammatory rheumatic condition in this age group, after rheumatoid arthritis. Polymyalgia rheumatica can occur independently or in association with giant cell arteritis,...
Uploaded on: August 27, 2024 -
2024 (v1)Publication
Objectives To inform an international task force about current evidence on Treat to Target (T2T) strategies in PMR and GCA.Methods A systematic literature research (SLR) was conducted in Medline, EMBASE, Cochrane Library, clinicaltrials.gov from their inception date to May 2022, and in the EULAR/ACR abstract database (2019-2021). Randomised...
Uploaded on: July 3, 2024 -
2015 (v1)Publication
To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia rheumatica (PMR). A systematic literature review was conducted using Ovid Medline, Embase, PubMed, CINAHL, Web of Science and the Cochrane Library (1970 through April 2014). Quality of evidence (QoE) of identified studies was appraised by Grading of...
Uploaded on: August 27, 2024 -
2020 (v1)Publication
No description
Uploaded on: August 27, 2024 -
2020 (v1)Publication
No description
Uploaded on: August 27, 2024 -
2015 (v1)Publication
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of...
Uploaded on: April 14, 2023 -
2023 (v1)Publication
Objectives: To develop an Outcome Measures in Rheumatology (OMERACT) ultrasonography score for monitoring disease activity in giant cell arteritis (GCA) and evaluate its metric properties.Methods: The OMERACT Instrument Selection Algorithm was followed. Forty-nine members of the OMERACT ultrasonography large vessel vasculitis working group were...
Uploaded on: August 27, 2024 -
2021 (v1)Publication
No description
Uploaded on: March 27, 2023